We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

BIONEER

Provides solutions for molecular diagnostics including nucleic acid extraction instruments, real-time PCR instruments... read more Featured Products: More products

Download Mobile App





Bioneer Presents Near-Patient POC Molecular Diagnostic System at MEDICA 2022

By LabMedica International staff writers
Posted on 16 Nov 2022

Bioneer Corp. More...

(Daejeon, Korea) is demonstrating its state-of-the-art molecular biology products and technologies at the 2022 edition of MEDICA, the world's largest trade fair for medical technology, being held from 14 to 17 November in Düsseldorf, Germany.

At MEDICA 2022, Bioneer is showcasing the AccuLoader which guides users to load samples into the correct wells of a multi-well plate by scanning each sample barcode and automatically moving the dispensing hole to the correct well. Loading conditions and sample information are easily managed using the included tablet and dedicated AccuLoader application. In addition, users can quickly pool a large number of samples without human error using the pool sample setting, and the sample shield and filter prevent cross-contamination while samples are being loaded. Bioneer is also highlighting the ExiPrep 96 Lite automated nucleic acid extractor with high capacity which has built-in protocols optimized for various kit applications for the extraction of nucleic acid. ExiPrep 96 Lite can extract viral RNA in 30 minutes with the Protonion Viral RNA Kit, which does not contain EtOH to prevent PCR inhibition and rapid extraction speed.

Alongside the ExiPrep 96 Lite, Bioneer is showcasing the ExiStation series of automated molecular diagnostic system composed of the ExiPrep 16 Dx nucleic acid extractor and Exicycler 96 Real-Time PCR. The system configuration is flexible and can connect up to three ExiPrep 16 Dx. The ExiStation 48 is composed of ExiPrep 48Dx nucleic acid extractor and the Exicycler 96 Real-Time PCR. The ExiStation series of automated molecular diagnostic system has been developed with Bioneer’s patented technologies and are adjustable to lab conditions. The ExiStation series are optimized for vacuum-dried premix kits and adapted with four-layer contamination protection for constant test accuracy.

At MEDICA 2022, Bioneer is highlighting its new IRON-qPCR near-patient POC molecular diagnostic system which is fully automated and requires the user to just put the sample in to get the data out. The assays are done within 30 minutes and are suitable for near-patient diagnosis. The IRON-qPCR is also a two-cartridge type instrument with user-friendly operation steps using the touch screen, and can handle up to 40 pathogens at once for syndrome diagnosis. Visitors to Bioneer’s booth at MEDICA 2022 can experience the ExiStation FA 96/384 fully automated molecular diagnostic system that is capable of automated de-capping and capping primary sample tubes inside the system. It does not require negative-pressure facility such as BSC and helps generate consistent results without human error. Visitors can also experience the LH 384 fully automated liquid handler that transfers extracted nucleic acid to PCR preparation. It transfers extracted nucleic acid from 96 well plates to a 96/384 well plate or tubes. With Bioneer’s premix cartridges, user can easily prepare samples for PCR by simply sealing the PCR plate or tubes.

Related Links:
Bioneer Corp.


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
H-FABP Assay
Heart-Type Fatty Acid-Binding Protein Assay
Urine Analyzer
respons® UDS100
New
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The researchers Manel Pérez Pons y Carlos Rodriguez Muñoz at the IRBLleida laboratory (Photo courtesy of IRBLleida)

New Blood RNA Markers Help Advance Precision Medicine for Respiratory Patients

Risk stratification in hospitalized respiratory disease, particularly among older adults with COVID-19, remains challenging despite rich clinical datasets. Blood-based non-coding RNA biomarkers are promising,... Read more

Microbiology

view channel
Image: The “broth” used to monitor red blood cell depletion in whole blood spiked with one colony-forming-unit of E. coli bacteria, each incubated at different orbital shaking speeds—left to right: 0 RPM, 65 RPM, 120 RPM and 200 RPM—after four hours of incubation. This culturing raises a bacteria-rich, plasma-like layer of bacteria to the top of the vials, while clusters of stuck blood cells known as a Rouleaux formation sink to the bottom. (Image Credit: Pak Kin Wong)

New Diagnostic Workflow Identifies Bloodstream Pathogens and Antibiotic Response in Hours

Sepsis is a life-threatening complication of infection that affects more than 1.5 million patients annually in the United States and contributes to roughly one in three in-hospital deaths.... Read more

Pathology

view channel
Image: Researchers evaluated AI models that quantify tumor-infiltrating lymphocytes (TIL) on routine breast tissue slides, where higher TIL levels reflect stronger antitumor response and improved breast cancer outcomes (Image Credit: Shutterstock)

AI Matches Pathologists in Predicting Breast Cancer Prognosis from Immune Cells

Breast cancer is the most common cancer in Australian women, with more than 20,000 cases each year. Prognosis can be informed by counting tumor-infiltrating lymphocytes (TILs) on routine pathology slides,... Read more

Industry

view channel
Image: RaDaR ST uses a tumor-informed approach that identifies up to 48 patient-specific variants through whole-exome sequencing and tracks those variants in plasma to detect circulating tumor DNA (ctDNA) at very low variant allele fractions (VAFs) (Photo courtesy of Neogenomics)

Tumor-Informed MRD Assay Gains Medicare Coverage for Immunotherapy Monitoring

NeoGenomics’ RaDaR ST molecular residual disease (MRD) assay has received expanded coverage from the Centers for Medicare & Medicaid Services’ Molecular Diagnostic Services Program (MolDX) for monitoring... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.